V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215686 | 20155653 | 1.7 | 100.6 | Palliative (P) | 2016-12-19 | 2017-01-16 | Trial Unspecified | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100581575 |
| 20215689 | 20155654 | 1.69 | 59.5 | Palliative (P) | 2019-04-12 | 2019-04-25 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100573998 |
| 20215690 | 20155655 | 1.6 | 56.3 | Palliative (P) | 2017-02-16 | 2017-06-20 | Sorafenib | 02 | N | SORAFENIB | 100583102 |
| 20215691 | 20155656 | 1.64 | null | null | 2019-02-24 | 2019-04-09 | Trial Unspecified | 02 | N | OXALIPLATIN + RALTITREXED | 101423484 |
| 20215693 | 20155657 | 1.66 | 69.6 | Palliative (P) | 2019-07-12 | 2019-07-12 | EOX | 99 | N | CETUXIMAB + IRINOTECAN + MDG | 100355171 |
| 20215694 | 20155658 | 1.92 | 81.9 | Palliative (P) | 2017-09-26 | 2017-10-07 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101437009 |
| 20215704 | 20155659 | 1.66 | 81.4 | Palliative (P) | 2020-08-07 | 2020-08-29 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100902126 |
| 20215707 | 20155660 | null | null | Palliative (P) | 2019-08-28 | 2019-09-08 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101813519 |
| 20215709 | 20155661 | 1.6 | 58.5 | Palliative (P) | 2018-04-06 | 2018-05-03 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100495429 |
| 20215710 | 20155662 | 1.7 | 86.9 | Neo-adjuvant (N) | 2017-05-03 | 2017-05-22 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100807570 |
| 20215714 | 20155663 | 1.58 | 40.4 | Palliative (P) | 2019-02-17 | 2019-03-11 | EOX | N | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100398081 |
| 20215715 | 20155664 | 1.62 | 78 | Palliative (P) | 2019-07-02 | 2019-07-14 | EOX | 02 | N | TRIAL | 101268376 |
| 20215716 | 20155665 | 1.84 | 47.3 | Palliative (P) | 2018-04-25 | 2018-05-01 | Oxaliplatin + Raltitrexed | Y | N | OXALIPLATIN + RALTITREXED | 101488633 |
| 20215717 | 20155666 | 1.57 | 65.4 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-14 | EOX | N | N | EOX | 100128154 |
| 20215721 | 20155667 | null | 91 | Palliative (P) | 2020-03-30 | 2020-03-31 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100662723 |
| 20215725 | 20155668 | 1.67 | 70.1 | Palliative (P) | 2019-01-20 | 2019-03-13 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 101322806 |
| 20215726 | 20155669 | 1.78 | 85.9 | null | 2019-04-18 | 2019-04-18 | EOX | 2 | null | EOX | 101127910 |
| 20215731 | 20155670 | 1.46 | 120 | null | 2017-06-24 | 2017-07-23 | EOX | 02 | Y | EOX | 100880529 |
| 20215732 | 20155671 | 1.82 | 48 | null | 2017-12-31 | 2018-01-27 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101453556 |
| 20215734 | 20155672 | 1.67 | 77.6 | Adjuvant (A) | 2017-12-06 | 2017-12-16 | Trial Unspecified | 02 | N | TRIAL | 101039427 |
| 20215735 | 20155673 | 1.61 | 62.8 | Neo-adjuvant (N) | 2018-03-02 | 2018-03-09 | Oxaliplatin + Raltitrexed | 01 | N | OXALIPLATIN + RALTITREXED | 101765996 |
| 20215738 | 20155674 | null | 84.6 | Neo-adjuvant (N) | 2020-07-04 | 2020-07-11 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100982184 |
| 20215740 | 20155675 | 1.75 | 85 | Palliative (P) | 2020-02-28 | 2020-03-10 | Trial Unspecified | 02 | N | OXALIPLATIN + RALTITREXED | 101858357 |
| 20215752 | 20155676 | 1.59 | 61.9 | Palliative (P) | 2016-12-24 | 2020-06-14 | Cetuximab + FOLFIRI cycle1 | N | N | CETUXIMAB + IRINOTECAN + MDG | 100754588 |
| 20215753 | 20155677 | 1.75 | 61 | Neo-adjuvant (N) | null | 2019-10-19 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100945170 |
| 20215756 | 20155678 | 1.59 | 43.5 | Palliative (P) | 2018-10-16 | 2018-10-24 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100675504 |
| 20215757 | 20155679 | 1.91 | 77.1 | Palliative (P) | 2021-03-14 | 2021-04-04 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101776537 |
| 20215760 | 20155680 | 1.78 | 47.8 | Neo-adjuvant (N) | 2020-02-12 | 2020-02-26 | EOX | 2 | N | TRIAL | 101092492 |
| 20215767 | 20155681 | 1.84 | 84.75 | Palliative (P) | 2018-09-30 | 2018-10-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100761428 |
| 20215774 | 20155682 | 1.58 | 79.5 | Palliative (P) | 2020-12-04 | 2021-01-05 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100703986 |
| 20215775 | 20155683 | 1.78 | 51.2 | Palliative (P) | 2020-01-30 | 2020-01-30 | Capecitabine 42days + RT | N | N | CAPECITABINE + RT | 101280717 |
| 20215776 | 20155684 | 1.6 | 114.4 | Palliative (P) | 2020-01-03 | 2020-01-17 | Trial Unspecified | N | N | TRIAL | 101590620 |
| 20215778 | 20155685 | 1.63 | 48 | Palliative (P) | 2017-03-16 | 2017-06-28 | GO2 TRIAL | 2 | N | TRIAL | 100912373 |
| 20215780 | 20155686 | 1.87 | 74.3 | Palliative (P) | 2020-08-26 | 2020-08-31 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101515440 |
| 20215781 | 20155687 | 1.46 | 71.4 | null | 2016-10-17 | 2016-10-17 | IRINOTECAN + MDG + PANITUMUMAB | 01 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101565419 |
| 20215788 | 20155688 | 1.91 | 84.7 | Palliative (P) | 2019-09-10 | 2019-11-15 | IRINOTECAN + MDG + PANITUMUMAB | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101832335 |
| 20215790 | 20155689 | 1.7 | 82.8 | Curative (C) | 2020-03-29 | 2020-04-26 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101796850 |
| 20215791 | 20155690 | 1.58 | 45.7 | Palliative (P) | 2017-08-23 | 2017-08-31 | Panitumumab + Irinotecan + MdG | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101194513 |
| 20215794 | 20155691 | 1.63 | 54.3 | 03 | 2017-03-30 | 2017-04-08 | Sorafenib | 02 | N | SORAFENIB | 100733981 |
| 20215795 | 20155692 | 1.63 | 48.7 | null | 2022-04-03 | 2022-04-15 | EOX | 2 | Y | CETUXIMAB + IRINOTECAN + MDG | 101118523 |
| 20215796 | 20155693 | 1.67 | 100 | null | 2019-12-05 | 2019-12-06 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100380832 |
| 20215797 | 20155694 | 1.79 | 53 | Palliative (P) | 2016-09-13 | 2016-09-13 | EOX | 99 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100481215 |
| 20215799 | 20155695 | 1.67 | 112 | Palliative (P) | 2017-06-04 | 2017-06-16 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101218620 |
| 20215802 | 20155696 | 1.62 | 76.4 | Palliative (P) | 2017-08-03 | 2017-08-26 | Sorafenib | 02 | null | SORAFENIB | 100572214 |
| 20215807 | 20155697 | 1.78 | 73.9 | null | 2017-11-01 | 2017-11-08 | Sorafenib | 02 | null | SORAFENIB | 100663324 |
| 20215808 | 20155698 | 1.62 | 64.2 | Neo-adjuvant (N) | null | 2020-05-25 | Trial Unspecified | 1 | N | TRIAL | 100869446 |
| 20215810 | 20155699 | 1.7 | 107 | Palliative (P) | 2019-01-27 | 2019-04-02 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | EOX | 100943986 |
| 20215811 | 20155700 | 1.82 | 68.2 | Adjuvant (A) | 2020-07-28 | 2020-08-17 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101580733 |
| 20215812 | 20155701 | 1.79 | 0 | Curative (C) | 2018-09-22 | 2018-09-22 | Trial Unspecified | N | N | TRIAL | 101412970 |
| 20215813 | 20155702 | 1.74 | 53.6 | Palliative (P) | 2019-04-28 | 2019-05-23 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100361771 |